This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Norén-Nyström U, Roos G, Bergh A, Forestier E . Prognostic impact of vascular density and fibrosis in the bone marrow of children with high-risk acute lymphoblastic leukemia. Leukemia 2005; 19: 1998–2001.
Norén-Nyström U, Roos G, Bergh A, Botling J, Lonnerholm G, Porwit A et al. Bone marrow fibrosis in childhood acute lymphoblastic leukemia correlates to biological factors, treatment response and outcome. Leukemia 2008; 22: 504–510.
Norén-Nyström U, Heyman M, Frisk P, Golovleva I, Sundstrom C, Porwit A et al. Vascular density in childhood acute lymphoblastic leukaemia correlates to biological factors and outcome. Br J Haematol 2009; 146: 521–530.
Hann IM, Evans DI, Marsden HB, Jones PM, Palmer MK . Bone marrow fibrosis in acute lymphoblastic leukaemia of childhood. J Clin Pathol 1978; 31: 313–315.
Pule MA, Gullmann C, Dennis D, McMahon C, Jeffers M, Smith OP . Increased angiogenesis in bone marrow of children with acute lymphoblastic leukaemia has no prognostic significance. Br J Haematol 2002; 118: 991–998.
Bancroft JSA . Theory and Practice of Histological Techniques. Churchill Livingstone: New York, 1982, pp. 142–143.
Bain BJCD, Lampert IA, Wilkins BS . Bone Marrow Pathology, 3rd edn. Blackwell Scientific 2001, 512 pp.
Flohr T, Schrauder A, Cazzaniga G, Panzer-Grumayer R, van der Velden V, Fischer S et al. Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia. Leukemia 2008; 22: 771–782.
Sutton R, Venn NC, Tolisano J, Bahar AY, Giles JE, Ashton LJ et al. Clinical significance of minimal residual disease at day 15 and at the end of therapy in childhood acute lymphoblastic leukaemia. Br J Haematol 2009; 146: 292–299.
Acknowledgements
We thank Mary Carli for technical assistance, Peter Baghurst for statistical advice and Andrew Zannetino for valuable advice with the manuscript. We acknowledge the NH&MRC, the Cancer Council of NSW and the Leukaemia Foundation for their financial support of MRD studies and the ANZCHOG study 8 committee. Standardization and quality control for MRD testing is supported by EuroMRD. Children's Cancer Institute Australia for Medical Research is affiliated to both the University of New South Wales and the Sydney Children's Hospital.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Bharos, A., Jong, AJ., Manton, N. et al. Bone marrow fibrosis and vascular density lack prognostic significance in childhood acute lymphoblastic leukaemia. Leukemia 24, 1537–1538 (2010). https://doi.org/10.1038/leu.2010.134
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2010.134
This article is cited by
-
Bone marrow fibrosis as prognostic marker in adult patients with acute lymphoblastic leukemia
Journal of Hematopathology (2019)
-
Bone marrow fibrosis at diagnosis predicts survival for primary acute myeloid leukemia
Clinical and Translational Oncology (2017)